Preprint · OA
via OpenAlex
Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19
Amjad Husain, Siddappa N. Byrareddy
Chemico-Biological Interactions · 2020 · ▲ 81 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.cbi.2020.109282
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Husain, A., & Byrareddy, S.N. (2020). Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19. <em>Chemico-Biological Interactions</em>. https://doi.org/10.1016/j.cbi.2020.109282
Vancouver
Husain A, Byrareddy SN. Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19. Chemico-Biological Interactions. 2020. doi:10.1016/j.cbi.2020.109282.
BibTeX
@unpublished{amjad2020Rapamy,
title = {Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19},
author = {Amjad Husain and Siddappa N. Byrareddy},
journal = {Chemico-Biological Interactions},
year = {2020},
doi = {10.1016/j.cbi.2020.109282},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
American Journal of Ophthalmology 2007
Citation only
Ranibizumab According to Need: A Treatment for Age-related Macular Degeneration
Journal of Allergy and Clinical Immunology 2020
Open access · OA
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
Mayo Clinic Proceedings 2008
Open access · OA
Frailty and Its Potential Relevance to Cardiovascular Care
Current Opinion in Genetics & Development 2014
Preprint · OA
Circadian clock: linking epigenetics to aging
Disease Models & Mechanisms 2021
Open access · CC-BY
Rapamycin modulates pulmonary pathology in a murine model of Mycobacterium tuberculosis infection
Innovation in aging 2025
Open access · OA